Works matching DE "OLANZAPINE"
Results: 2690
Variation in the management of hypothetical cases of acute agitation in Australasian emergency departments.
- Published in:
- Emergency Medicine Australasia, 2011, v. 23, n. 1, p. 23, doi. 10.1111/j.1742-6723.2010.01348.x
- By:
- Publication type:
- Article
Antipsychotics use in the community of Thessaloniki, Greece.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2018, v. 75, n. 5, p. 468, doi. 10.2298/VSP160917327P
- By:
- Publication type:
- Article
Decision models in the evaluation of psychotropic drugs.
- Published in:
- European Journal of Health Economics, 2006, v. 7, n. 3, p. 218, doi. 10.1007/s10198-006-0348-z
- By:
- Publication type:
- Article
Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia relapse in Germany.
- Published in:
- European Journal of Health Economics, 2003, v. 4, n. 2, p. 85, doi. 10.1007/s10198-002-0161-2
- By:
- Publication type:
- Article
The use of Atypical antipsychotics in French psychiatric hospitals.
- Published in:
- Pharmacy World & Science, 2007, v. 29, n. 5, p. 551, doi. 10.1007/s11096-007-9107-1
- By:
- Publication type:
- Article
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.
- Published in:
- Alcohol, Clinical & Experimental Research, 2023, v. 47, n. 9, p. 1629, doi. 10.1111/acer.15143
- By:
- Publication type:
- Article
A case of schizophrenia-like psychosis due to Fahr's disease.
- Published in:
- Archives of Mental Health, 2023, v. 24, n. 1, p. 49, doi. 10.4103/amh.amh_33_22
- By:
- Publication type:
- Article
Neuroleptic-induced tardive dystonia in young patients suffering from psychosis.
- Published in:
- Archives of Mental Health, 2022, v. 23, n. 2, p. 144, doi. 10.4103/amh.amh_10_22
- By:
- Publication type:
- Article
Metabolic Syndrome in Schizophrenia Patients on Antipsychotics: A Cross-Sectional Study.
- Published in:
- Journal of Positive School Psychology, 2022, v. 6, n. 3, p. 6635
- By:
- Publication type:
- Article
Olanzapine-induced restless leg syndrome (Willis–Ekbom disease): A case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Use of Intramuscular Chlorpromazine Versus Intramuscular Olanzapine for the Management of Acute Agitation and Aggression in Youth.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2021, v. 26, n. 1, p. 33, doi. 10.5863/1551-6776-26.1.33
- By:
- Publication type:
- Article
Olanzapine-Induced Withdrawal Oculogyric Crisis in an Adolescent With a Neurodevelopmental Disorder.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
A Retrospective Review of Antipsychotic Medications Administered to Psychiatric Patients in a Tertiary Care Pediatric Emergency Department.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2019, v. 24, n. 3, p. 234, doi. 10.5863/1551-6776-24.3.234
- By:
- Publication type:
- Article
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
- Published in:
- BJPsych Advances, 2018, v. 24, n. 6, p. 360, doi. 10.1192/bja.2018.51
- By:
- Publication type:
- Article
Formulation, in vitro and in vivo evaluation of olanzapine nanoparticles dissolving microneedles for transdermal delivery.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e120974
- By:
- Publication type:
- Article
Role of D<sub>2</sub> receptor (-141 C Ins/Del) genetic polymorphism on olanzapine-induced adverse drug reaction in schizophrenic patients.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e112064
- By:
- Publication type:
- Article
Association study between D<sub>2</sub> receptor A-241G, rs1799978 genetic variation and olanzapine efficacy in Iraqi schizophrenic patients.
- Published in:
- Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e111984
- By:
- Publication type:
- Article
Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment.
- Published in:
- Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2023, v. 32, n. 3, p. 128, doi. 10.5114/ppn.2023.132493
- By:
- Publication type:
- Article
Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll‐HD Database.
- Published in:
- Movement Disorders Clinical Practice, 2019, v. 6, n. 2, p. 132, doi. 10.1002/mdc3.12706
- By:
- Publication type:
- Article
Synthesis and analysis of Ag/olanzapine/cyclodextrin and Ag/Co/Olanzapine/cyclodextrin inclusion complex nanorods.
- Published in:
- Physics & Chemistry of Liquids, 2024, v. 62, n. 3, p. 196, doi. 10.1080/00319104.2023.2297223
- By:
- Publication type:
- Article
Pragmatic clinical trials to advance research in children and adolescents with eating disorders.
- Published in:
- International Journal of Eating Disorders, 2024, v. 57, n. 6, p. 1350, doi. 10.1002/eat.24209
- By:
- Publication type:
- Article
Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.
- Published in:
- International Journal of Eating Disorders, 2012, v. 45, n. 2, p. 294, doi. 10.1002/eat.20917
- By:
- Publication type:
- Article
Olanzapine Treatment of Anorexia Nervosa: A Retrospective Study.
- Published in:
- International Journal of Eating Disorders, 2003, v. 33, n. 2, p. 234, doi. 10.1002/eat.10122
- By:
- Publication type:
- Article
Olanzapine Use as an Adjunctive Treatment for Hospitalized Children with Anorexia Nervosa: Case Reports.
- Published in:
- International Journal of Eating Disorders, 2003, v. 33, n. 1, p. 98, doi. 10.1002/eat.10115
- By:
- Publication type:
- Article
Olanzapine in the Treatment of Anorexia Nervosa: An Open Label Trial.
- Published in:
- International Journal of Eating Disorders, 2002, v. 32, n. 2, p. 146, doi. 10.1002/eat.10084
- By:
- Publication type:
- Article
Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine.
- Published in:
- Journal of Parathyroid Disease, 2018, v. 6, n. 1, p. 19, doi. 10.15171/jpd.2018.07
- By:
- Publication type:
- Article
Clinical practice of rational use of clozapine and olanzapine based on therapeutic drug monitoring.
- Published in:
- Pharmaceutial Care & Research, 2019, p. 465, doi. 10.5428/pcar20190618
- By:
- Publication type:
- Article
Cerebral Computed Tomographic Findings in Schizophrenia: Relationship to Second-Generation Antipsychotics and Hyperprolactinemia.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 13, p. 1343, doi. 10.3390/healthcare12131343
- By:
- Publication type:
- Article
SCHIZOFRENIE V ADOLESCENCI A JEJÍ LÉČBA.
- Published in:
- Ceská a Slovenská Psychiatrie, 2022, v. 118, n. 4, p. 163
- By:
- Publication type:
- Article
LURASIDON V LÉČBĚ PACIENTA SE SCHIZOFRENIÍ A METABOLICKÝM SYNDROMEM.
- Published in:
- Ceská a Slovenská Psychiatrie, 2020, v. 116, n. 5, p. 251
- By:
- Publication type:
- Article
Dispensed prescriptions for quetiapine and other secondgeneration antipsychotics in Canada from 2005 to 2012: a descriptive study.
- Published in:
- CMAJ Open, 2014, v. 2, n. 4, p. E225, doi. 10.9778/cmajo.20140009
- By:
- Publication type:
- Article
Clinical usefulness of metagenomic next-generation sequencing for Rickettsia and Coxiella burnetii diagnosis.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 6, p. 681, doi. 10.1007/s10096-023-04586-w
- By:
- Publication type:
- Article
Cisplatin-Based Therapy and CINV: Optimal antiemetics during germ cell testicular cancer treatment.
- Published in:
- Clinical Journal of Oncology Nursing, 2018, v. 22, n. 2, p. E31, doi. 10.1188/18.CJON.E31-E36
- By:
- Publication type:
- Article
Change in the spectral characteristics of olanzapine upon protonation.
- Published in:
- Doklady Chemistry, 2010, v. 434, n. 2, p. 260, doi. 10.1134/S0012500810100034
- By:
- Publication type:
- Article
Correlation between surrogate endpoints and overall survival in unresectable hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-54945-6
- By:
- Publication type:
- Article
Computerized text and voice analysis of patients with chronic schizophrenia in art therapy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43069-y
- By:
- Publication type:
- Article
CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45752-6
- By:
- Publication type:
- Article
Computerized text and voice analysis of patients with chronic schizophrenia in art therapy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43069-y
- By:
- Publication type:
- Article
SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42989-z
- By:
- Publication type:
- Article
Revisiting and updating molecular epidemiology of α-thalassemia mutations in Thailand using MLPA and new multiplex gap-PCR for nine α-thalassemia deletion.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36840-8
- By:
- Publication type:
- Article
Permütasyon Entropi Tabanlı Karmaşıklık Analizi ile EEG İşaretlerinden Şizofreni Tespiti.
- Published in:
- Journal of the Institute of Science & Technology / Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2022, v. 12, n. 4, p. 2085, doi. 10.21597/jist.1122315
- By:
- Publication type:
- Article
Population pharmacokinetics and dosing optimization of olanzapine in Chinese paediatric patients: Based on the impact of sex and concomitant valproate on clearance.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 11, p. 1811, doi. 10.1111/jcpt.13770
- By:
- Publication type:
- Article
Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2011, v. 36, n. 2, p. 172, doi. 10.1111/j.1365-2710.2010.01175.x
- By:
- Publication type:
- Article
Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2010, v. 35, n. 2, p. 207, doi. 10.1111/j.1365-2710.2009.01084.x
- By:
- Publication type:
- Article
Lack of association between the −759C/T polymorphism of the 5-HT2<sub>C</sub> receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2008, v. 33, n. 1, p. 55, doi. 10.1111/j.1365-2710.2008.00872.x
- By:
- Publication type:
- Article
Clozapine–olanzapine: a potentially dangerous switch. A report of two cases.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 1999, v. 24, n. 3, p. 191, doi. 10.1046/j.1365-2710.1999.00218.x
- By:
- Publication type:
- Article
Infections associated with clozapine: a pharmacovigilance study using VigiBase<sup>®</sup>.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1260915
- By:
- Publication type:
- Article
Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1255501
- By:
- Publication type:
- Article
Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1182393
- By:
- Publication type:
- Article
Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1166507
- By:
- Publication type:
- Article